Do analysts prefer SLS or APHA?

Solaris Resources presently has a consensus target price of C$19.50, suggesting a potential upside of 57.77%. Given Solaris Resources' stronger consensus rating and higher probable upside, research analysts clearly believe Solaris Resources is more favorable than Aphria. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is SLS or APHA more profitable?

Solaris Resources' return on equity of 60.97% beat Aphria's return on equity. Company Net Margins Return on Equity Return on Assets Solaris Resources N/A 60.97% -51.67% Aphria N/A N/A N/A

Does the media prefer SLS or PBH?

In the previous week, Premium Brands had 3 more articles in the media than Solaris Resources. MarketBeat recorded 4 mentions for Premium Brands and 1 mentions for Solaris Resources. Premium Brands' average media sentiment score of 0.19 beat Solaris Resources' score of 0.00 indicating that Premium Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solaris Resources 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Premium Brands 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate BHC or SLS?

Solaris Resources has a consensus target price of C$19.50, indicating a potential upside of 57.77%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts clearly believe Solaris Resources is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts recommend AUP or SLS?

Solaris Resources has a consensus price target of C$19.50, indicating a potential upside of 57.77%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Aurinia Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Is AUP or SLS more profitable?

Solaris Resources' return on equity of 60.97% beat Aurinia Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Aurinia Pharmaceuticals N/A N/A N/A Solaris Resources N/A 60.97% -51.67%

Do analysts recommend CARA or SLS?

Solaris Resources has a consensus target price of C$19.50, suggesting a potential upside of 57.77%. Given Solaris Resources' stronger consensus rating and higher probable upside, analysts plainly believe Solaris Resources is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable earnings and valuation, CARA or SLS?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cara Operations N/A N/A N/A N/A N/A Solaris Resources N/A N/A -C$46.49M -C$0.19 N/A

Is CARA or SLS more profitable?

Solaris Resources' return on equity of 60.97% beat Cara Operations' return on equity. Company Net Margins Return on Equity Return on Assets Cara Operations N/A N/A N/A Solaris Resources N/A 60.97% -51.67%

Solaris Resources (SLS) Competitors

C$12.36 +0.29 (+2.40%)

As of 07/3/2026 04:00 PM Eastern

Compare

SLS vs. APHA, PBH, BHC, AUP, and CARA

Should you buy Solaris Resources stock or one of its competitors? MarketBeat compares Solaris Resources with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Solaris Resources include Aphria (APHA), Premium Brands (PBH), Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), and Cara Operations (CARA). These companies are all part of the "pharmaceutical products" industry.

How does Solaris Resources compare to Aphria?

Solaris Resources (TSE:SLS) and Aphria (TSE:APHA) are both mid-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

In the previous week, Solaris Resources had 1 more articles in the media than Aphria. MarketBeat recorded 1 mentions for Solaris Resources and 0 mentions for Aphria. Solaris Resources' average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company	Overall Sentiment
Solaris Resources	Neutral
Aphria	Neutral

Solaris Resources presently has a consensus target price of C$19.50, suggesting a potential upside of 57.77%. Given Solaris Resources' stronger consensus rating and higher probable upside, research analysts clearly believe Solaris Resources is more favorable than Aphria.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Solaris Resources has higher earnings, but lower revenue than Aphria. Solaris Resources is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A

16.4% of Solaris Resources shares are held by institutional investors. 40.6% of Solaris Resources shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Solaris Resources' return on equity of 60.97% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Aphria	N/A	N/A	N/A

Summary

Solaris Resources beats Aphria on 9 of the 12 factors compared between the two stocks.

How does Solaris Resources compare to Premium Brands?

Solaris Resources (TSE:SLS) and Premium Brands (TSE:PBH) are both mid-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Solaris Resources has a beta of 1.721408, suggesting that its stock price is 72% more volatile than the broader market. Comparatively, Premium Brands has a beta of 0.88205, suggesting that its stock price is 12% less volatile than the broader market.

Premium Brands has a net margin of 0.52% compared to Solaris Resources' net margin of 0.00%. Solaris Resources' return on equity of 60.97% beat Premium Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Premium Brands	0.52%	2.21%	3.61%

Premium Brands has higher revenue and earnings than Solaris Resources. Solaris Resources is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Premium Brands	C$7.88B	0.56	C$99.56M	C$0.90	94.70

Solaris Resources currently has a consensus price target of C$19.50, suggesting a potential upside of 57.77%. Premium Brands has a consensus price target of C$118.62, suggesting a potential upside of 39.17%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Premium Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92

16.4% of Solaris Resources shares are held by institutional investors. Comparatively, 32.9% of Premium Brands shares are held by institutional investors. 40.6% of Solaris Resources shares are held by company insiders. Comparatively, 2.0% of Premium Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Premium Brands had 3 more articles in the media than Solaris Resources. MarketBeat recorded 4 mentions for Premium Brands and 1 mentions for Solaris Resources. Premium Brands' average media sentiment score of 0.19 beat Solaris Resources' score of 0.00 indicating that Premium Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solaris Resources	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Premium Brands	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Premium Brands beats Solaris Resources on 10 of the 15 factors compared between the two stocks.

How does Solaris Resources compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Solaris Resources (TSE:SLS) are both mid-cap pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

In the previous week, Solaris Resources had 1 more articles in the media than Bausch Health Companies. MarketBeat recorded 1 mentions for Solaris Resources and 0 mentions for Bausch Health Companies. Bausch Health Companies' average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score.

Company	Overall Sentiment
Bausch Health Companies	Neutral
Solaris Resources	Neutral

Solaris Resources has lower revenue, but higher earnings than Bausch Health Companies. Solaris Resources is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.25	-C$125.65M	-C$3.24	N/A
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A

Solaris Resources has a consensus target price of C$19.50, indicating a potential upside of 57.77%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts clearly believe Solaris Resources is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

11.3% of Bausch Health Companies shares are held by institutional investors. Comparatively, 16.4% of Solaris Resources shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Comparatively, 40.6% of Solaris Resources shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Bausch Health Companies has a beta of 0.942978, indicating that its stock price is 6% less volatile than the broader market. Comparatively, Solaris Resources has a beta of 1.721408, indicating that its stock price is 72% more volatile than the broader market.

Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Solaris Resources' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Solaris Resources	N/A	60.97%	-51.67%

Summary

Solaris Resources beats Bausch Health Companies on 10 of the 14 factors compared between the two stocks.

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Solaris Resources (TSE:SLS) are both mid-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

16.4% of Solaris Resources shares are held by institutional investors. 40.6% of Solaris Resources shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Solaris Resources' return on equity of 60.97% beat Aurinia Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurinia Pharmaceuticals	N/A	N/A	N/A
Solaris Resources	N/A	60.97%	-51.67%

Solaris Resources has lower revenue, but higher earnings than Aurinia Pharmaceuticals. Solaris Resources is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A

Solaris Resources has a consensus price target of C$19.50, indicating a potential upside of 57.77%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Aurinia Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Solaris Resources had 1 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 1 mentions for Solaris Resources and 0 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score.

Company	Overall Sentiment
Aurinia Pharmaceuticals	Neutral
Solaris Resources	Neutral

Summary

Solaris Resources beats Aurinia Pharmaceuticals on 9 of the 12 factors compared between the two stocks.

How does Solaris Resources compare to Cara Operations?

Cara Operations (TSE:CARA) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

Solaris Resources has a consensus target price of C$19.50, suggesting a potential upside of 57.77%. Given Solaris Resources' stronger consensus rating and higher probable upside, analysts plainly believe Solaris Resources is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Solaris Resources' return on equity of 60.97% beat Cara Operations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cara Operations	N/A	N/A	N/A
Solaris Resources	N/A	60.97%	-51.67%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cara Operations	N/A	N/A	N/A	N/A	N/A
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A

In the previous week, Solaris Resources had 1 more articles in the media than Cara Operations. MarketBeat recorded 1 mentions for Solaris Resources and 0 mentions for Cara Operations. Cara Operations' average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score.

Company	Overall Sentiment
Cara Operations	Neutral
Solaris Resources	Neutral

Summary

Solaris Resources beats Cara Operations on 7 of the 8 factors compared between the two stocks.

Get Solaris Resources News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SLS vs. The Competition

Export

Metric	Solaris Resources	Other Precious Metals & Mining Industry	Materials Sector	TSE Exchange
Market Cap	C$2.06B	C$622.17M	C$4.68B	C$13.07B
Dividend Yield	N/A	6.10%	5.02%	6.18%
P/E Ratio	-65.05	12.80	21.47	36.51
Price / Sales	N/A	3,596.69	6,344.52	10.34
Price / Cash	64.53	13.04	26.81	82.29
Price / Book	-40.98	55.61	8.78	4.52
Net Income	-C$46.49M	-C$4.87M	C$157.26M	C$299.09M
7 Day Performance	4.57%	2.87%	1.40%	1.85%
1 Month Performance	1.23%	-2.00%	-1.84%	1.71%
1 Year Performance	64.14%	60.42%	46.42%	36.40%

Solaris Resources Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SLS Solaris Resources	1.373 of 5 stars	C$12.36 +2.4%	C$19.50 +57.8%	+64.1%	C$2.06B	N/A	N/A	10	Gap Down
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
PBH Premium Brands	3.6774 of 5 stars	C$86.78 +1.7%	C$118.62 +36.7%	+1.7%	C$4.51B	C$7.88B	96.42	540	News Coverage
BHC Bausch Health Companies	0.2601 of 5 stars	C$7.49 +5.5%	N/A	-25.9%	C$2.80B	C$10.53B	N/A	19,900
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:SLS) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Solaris Resources (SLS) Competitors

SLS vs. APHA, PBH, BHC, AUP, and CARA

How does Solaris Resources compare to Aphria?

Summary

How does Solaris Resources compare to Premium Brands?

Summary

How does Solaris Resources compare to Bausch Health Companies?

Summary

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Summary

How does Solaris Resources compare to Cara Operations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLS vs. The Competition

Solaris Resources Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Solaris Resources (SLS) Competitors

SLS vs. APHA, PBH, BHC, AUP, and CARA

How does Solaris Resources compare to Aphria?

Does the media refer more to SLS or APHA?

Do analysts prefer SLS or APHA?

Which has stronger earnings & valuation, SLS or APHA?

Do insiders and institutionals have more ownership in SLS or APHA?

Is SLS or APHA more profitable?

Summary

How does Solaris Resources compare to Premium Brands?

Which has more risk and volatility, SLS or PBH?

Is SLS or PBH more profitable?

Which has better valuation & earnings, SLS or PBH?

Do analysts prefer SLS or PBH?

Do insiders & institutionals have more ownership in SLS or PBH?

Does the media prefer SLS or PBH?

Summary

How does Solaris Resources compare to Bausch Health Companies?

Does the media favor BHC or SLS?

Which has preferable valuation and earnings, BHC or SLS?

Do analysts rate BHC or SLS?

Do insiders and institutionals believe in BHC or SLS?

Which has more risk and volatility, BHC or SLS?

Is BHC or SLS more profitable?

Summary

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Do institutionals & insiders believe in AUP or SLS?

Is AUP or SLS more profitable?

Which has better valuation & earnings, AUP or SLS?

Do analysts recommend AUP or SLS?

Does the media refer more to AUP or SLS?

Summary

How does Solaris Resources compare to Cara Operations?

Do analysts recommend CARA or SLS?

Is CARA or SLS more profitable?

Which has preferable earnings and valuation, CARA or SLS?

Does the media prefer CARA or SLS?

Do institutionals and insiders have more ownership in CARA or SLS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLS vs. The Competition

Solaris Resources Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools